After COVID-19, what's next for EU medicines policies?
EPHA #A2MDialogues
Watch the discussion

9 March 2021

16:00-17:00 CET


Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe. 

A one-on-one interview with Professor Guido Rasi, former Executive Director, European Medicines Agency (EMA).

Professor Rasi will talk about about his time at the helm of Europe’s top regulator; the power balance between pharma and governments; the impact of the pandemic on the pharmaceutical regulatory framework and the innovation landscape and trends in Europe and beyond.





Professor Guido Rasi

Former Executive Director 

European Medicines Agency

Interviewed by

Yannis Natsis,

Policy Manager, Universal Access and Affordable Medicines

European Public Health Alliance

Catch up on EPHA’s other #A2MDialogues below

Getting it right: Recommendations for a European BARDA

8 December 2020

The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines

25 November 2020

Pharma & COVID19: Winners, losers, prospects

19 November  2020

The EU's IP strategy: Enabler or barrier?

27 October 2020

Unleashing meaningful innovation through regulatory reform

19 October 2020

Follow on social media




Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines, EPHA

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!